MEDICLIN Aktiengesellschaft (MED.DE)
EUR 2.42
(0.0%)
EUR 2.42
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 101.26 Million EUR | -30.34% |
| 2022 | 91.8 Million EUR | 7.46% |
| 2021 | 85.43 Million EUR | 10.01% |
| 2020 | 76.83 Million EUR | -17.17% |
| 2019 | 91.98 Million EUR | 149.2% |
| 2018 | 37.61 Million EUR | 38.27% |
| 2017 | 26.23 Million EUR | -37.17% |
| 2016 | 42.21 Million EUR | 2.82% |
| 2015 | 31.7 Million EUR | 23.45% |
| 2014 | 32.73 Million EUR | 73.09% |
| 2013 | 19.71 Million EUR | -9.46% |
| 2012 | 21.76 Million EUR | -22.15% |
| 2011 | 27.96 Million EUR | -9.54% |
| 2010 | 30.91 Million EUR | -2.32% |
| 2009 | 31.64 Million EUR | 13.58% |
| 2008 | 28.79 Million EUR | -70.08% |
| 2007 | 27.58 Million EUR | 4.82% |
| 2006 | 23.94 Million EUR | -67.58% |
| 2005 | 273.99 Million EUR | 2664.99% |
| 2004 | 9.9 Million EUR | 56.59% |
| 2003 | 6.32 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 20.24 Million EUR | 24.43% |
| 2024 Q1 | 16.18 Million EUR | -45.9% |
| 2023 Q4 | 30.48 Million EUR | -3.85% |
| 2023 Q2 | 27.05 Million EUR | 137.73% |
| 2023 Q3 | 31.7 Million EUR | 17.16% |
| 2023 Q1 | 11.38 Million EUR | -56.3% |
| 2023 FY | - EUR | -30.34% |
| 2022 Q3 | 23.09 Million EUR | -14.63% |
| 2022 FY | - EUR | 7.46% |
| 2022 Q1 | 15.6 Million EUR | -46.23% |
| 2022 Q4 | 26.04 Million EUR | 12.76% |
| 2022 Q2 | 27.05 Million EUR | 73.34% |
| 2021 Q1 | 6.47 Million EUR | -61.73% |
| 2021 Q2 | 16.75 Million EUR | 158.62% |
| 2021 Q3 | 33.16 Million EUR | 97.93% |
| 2021 Q4 | 29.02 Million EUR | -12.47% |
| 2021 FY | - EUR | 10.01% |
| 2020 Q4 | 16.93 Million EUR | -45.83% |
| 2020 FY | - EUR | -17.17% |
| 2020 Q3 | 31.25 Million EUR | 105.07% |
| 2020 Q2 | 15.24 Million EUR | 7.17% |
| 2020 Q1 | 14.22 Million EUR | -44.73% |
| 2019 Q2 | 22.28 Million EUR | 16.62% |
| 2019 Q4 | 25.73 Million EUR | -3.35% |
| 2019 FY | - EUR | 149.2% |
| 2019 Q1 | 19.11 Million EUR | 484.64% |
| 2019 Q3 | 26.62 Million EUR | 19.45% |
| 2018 Q4 | 3.26 Million EUR | -80.95% |
| 2018 FY | - EUR | 38.27% |
| 2018 Q1 | 6.09 Million EUR | 178.43% |
| 2018 Q2 | 11.09 Million EUR | 81.83% |
| 2018 Q3 | 17.16 Million EUR | 54.75% |
| 2017 Q4 | -7.77 Million EUR | -140.72% |
| 2017 Q3 | 19.09 Million EUR | 67.1% |
| 2017 Q2 | 11.42 Million EUR | 156.06% |
| 2017 Q1 | 4.46 Million EUR | -60.48% |
| 2017 FY | - EUR | -37.17% |
| 2016 Q1 | 6.39 Million EUR | -41.52% |
| 2016 Q2 | 12.07 Million EUR | 88.8% |
| 2016 Q3 | 13.54 Million EUR | 12.17% |
| 2016 Q4 | 11.29 Million EUR | -16.62% |
| 2016 FY | - EUR | 2.82% |
| 2015 Q4 | 10.93 Million EUR | -29.81% |
| 2015 FY | - EUR | 23.45% |
| 2015 Q3 | 15.57 Million EUR | 63.23% |
| 2015 Q2 | 9.54 Million EUR | 57.52% |
| 2015 Q1 | 6.05 Million EUR | -30.57% |
| 2014 Q2 | 8.48 Million EUR | 157.44% |
| 2014 Q1 | 3.29 Million EUR | -24.67% |
| 2014 Q4 | 8.72 Million EUR | -35.66% |
| 2014 Q3 | 13.56 Million EUR | 59.95% |
| 2014 FY | - EUR | 73.09% |
| 2013 Q2 | 6.68 Million EUR | 539.03% |
| 2013 Q4 | 4.37 Million EUR | -57.11% |
| 2013 FY | - EUR | -9.46% |
| 2013 Q1 | -1.52 Million EUR | -142.46% |
| 2013 Q3 | 10.19 Million EUR | 52.57% |
| 2012 Q2 | 6.18 Million EUR | 115.66% |
| 2012 Q3 | 9.2 Million EUR | 48.86% |
| 2012 Q4 | 3.58 Million EUR | -61.07% |
| 2012 FY | - EUR | -22.15% |
| 2012 Q1 | 2.86 Million EUR | -69.42% |
| 2011 Q2 | 9.36 Million EUR | 197.43% |
| 2011 Q4 | 9.37 Million EUR | 1.72% |
| 2011 Q1 | 3.14 Million EUR | -62.99% |
| 2011 FY | - EUR | -9.54% |
| 2011 Q3 | 9.21 Million EUR | -1.57% |
| 2010 Q4 | 8.5 Million EUR | -20.81% |
| 2010 Q3 | 10.74 Million EUR | 28.7% |
| 2010 Q2 | 8.34 Million EUR | 152.39% |
| 2010 Q1 | 3.3 Million EUR | -61.65% |
| 2010 FY | - EUR | -2.32% |
| 2009 Q4 | 8.62 Million EUR | -23.36% |
| 2009 FY | - EUR | 13.58% |
| 2009 Q1 | 3.04 Million EUR | 0.0% |
| 2009 Q3 | 11.25 Million EUR | 29.0% |
| 2009 Q2 | 8.72 Million EUR | 187.01% |
| 2008 FY | - EUR | -70.08% |
| 2007 FY | - EUR | 4.82% |
| 2006 FY | - EUR | -67.58% |
| 2005 FY | - EUR | 2664.99% |
| 2004 FY | - EUR | 56.59% |
| 2003 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 2.93 Billion EUR | 96.548% |
| Fresenius SE & Co. KGaA | 2.73 Billion EUR | 96.297% |
| LIMES Schlosskliniken AG | 854.98 Thousand EUR | -11744.051% |
| M1 Kliniken AG | 21.79 Million EUR | -364.671% |
| Maternus-Kliniken Aktiengesellschaft | 4.71 Million EUR | -2047.707% |
| RHÖN-KLINIKUM Aktiengesellschaft | 116.58 Million EUR | 13.139% |
| VITA 34 AG | 5.8 Million EUR | -1644.133% |